查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1507224

ADHD市場、佔有率、規模、趨勢、行業分析報告：依藥物類型、通路、人口統計、地區、細分市場預測，2024-2032年

Attention Deficit Hyperactivity Disorder Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Stimulants, Non-Stimulants); By Distribution Channel; By Demographics; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，預計到2032年，全球ADHD市場規模將達到305.6894億美元。本研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

ADHD盛行率的上升直接刺激了對診斷服務、治療介入和持續管理解決方案的需求，顯著推動了市場發展。醫療保健專業人員和公眾對ADHD症狀和對生活品質影響的認識不斷提高，導致診斷更加頻繁和更早。因此，藥物和行為治療（包括興奮劑和非興奮劑藥物）的市場日益擴大。

此外，認識到ADHD是一種需要長期管理的慢性疾病，將進一步推動市場成長，並鼓勵繼續研究和開發新的和增強的治療方案。人們越來越認識到ADHD在兒童和成人中都普遍存在，這日益擴大市場，並增加對針對不同年齡層和個人需求的各種治療的需求。

ADHD市場受到多種因素的影響，包括患病率上升、醫生和患者意識的提高以及診斷和治療方法的進步。然而，診斷不足、嚴格的監管流程和高昂的藥品成本等挑戰可能會阻礙未來的市場成長。市場競爭激烈，幾家主要製藥公司透過大力投資研發和廣泛的產品來引領市場。這些公司致力於創造新的和增強的藥物，包括興奮劑和非興奮劑藥物選擇，以滿足ADHD患者的多樣化需求。

ADHD市場報告要點

由於其在治療ADHD症狀方面的既定功效和快速起效，興奮劑類別佔據了最大的市場佔有率。

隨著對ADHD的認識和診斷不斷提高，醫院藥房行業預計在未來幾年將出現顯著成長。這一趨勢導致越來越多的患者尋求專門護理和綜合管理計劃，這些計劃通常由醫院提供。

到2023年，北美將因其 ADHD 的高診斷率而主導市場。這是由於該地區的醫療保健提供者和普通民眾對這種疾病的認識和認識不斷提高。

目錄

第1章 簡介

第2章 執行摘要

第3章 研究方法

第4章 全球 ADHD 市場洞察

  • ADHD行業概況
  • ADHD市場動態
    • 推動因素和機會
      • ADHD盛行率不斷上升
      • 輕鬆獲得行為復健治療
    • 抑制因素和挑戰
      • 缺乏足夠的補償
  • PESTEL 分析
  • ADHD市場的產業趨勢
  • 價值鏈分析
  • 新冠肺炎（COVID-19）影響分析

第5章 全球ADHD市場：依藥物類型

  • 主要發現
  • 簡介
  • 精神興奮劑
  • 非精神興奮劑

第6章 全球 ADHD 市場：依通路

  • 主要發現
  • 簡介
  • 零售藥局
  • 醫院藥房

第7章 全球ADHD市場：依人口統計

  • 主要發現
  • 簡介
  • 兒童（2 至 17 歲）
  • 成人

第8章 全球ADHD市場：依地區

  • 主要發現
  • 簡介
    • ADHD市場評估：依地區，2019-2032年
  • 北美
    • 北美：依藥物類型，2019-2032年
    • 北美：人口統計資料，2019-2032年
    • 北美：依通路，2019-2032年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依藥物類型，2019-2032年
    • 歐洲：人口統計資料，2019-2032年
    • 歐洲：依通路，2019-2032年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 亞太地區：依藥物類型，2019-2032年
    • 亞太地區：依人口統計資料，2019-2032年
    • 亞太地區：依通路，2019-2032年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東、非洲
    • 中東和非洲：依藥物類型，2019-2032年
    • 中東和非洲：按人口統計資料，2019-2032年
    • 中東與非洲：依通路，2019-2032年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依藥物類型，2019-2032年
    • 拉丁美洲：人口統計資料，2019-2032年
    • 拉丁美洲：依通路，2019-2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第9章 競爭態勢

  • 擴張與收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/揭露

第10章 公司簡介

  • ADVANZ PHARMA
  • Amneal Pharmaceuticals LLC
  • Aytu Biopharma, Inc
  • Eli Lilly and Company
  • Johnson & Johnson Services, Inc
  • Lupin
  • Mallinckrodt
  • Novartis AG
  • Noven Pharmaceuticals, Inc
  • Sun Pharmaceutical Industries Ltd
  • Supernus Pharmaceuticals, Inc
  • Takeda Pharmaceutical Company Limited
  • Torrent Pharmaceuticals Ltd
  • Tris Pharma, Inc
  • Zevra Therapeutics
Product Code: PM2960

The global Attention Deficit Hyperactivity Disorder market size is expected to reach USD 30,568.94 Million by 2032, according to a new study by Polaris Market Research. The report "Attention Deficit Hyperactivity Disorder Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Stimulants, Non-Stimulants); By Distribution Channel; By Demographics; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The escalating prevalence of Attention Deficit Hyperactivity Disorder significantly propels the market, directly stimulating the demand for diagnostic services, therapeutic interventions, and ongoing management solutions. Heightened awareness among healthcare professionals and the general public regarding ADHD symptoms and their impact on quality of life has led to more frequent and earlier diagnoses. Consequently, this has expanded the market for both pharmaceutical treatments, including stimulants and non-stimulants, and behavioral therapies.

Furthermore, the acknowledgment of ADHD as a chronic condition necessitating long-term management further drives market growth, fostering ongoing research and development of novel and enhanced treatment options. The expanding recognition of ADHD's prevalence among both children and adults broadens the market scope, fueling demand for diverse treatment modalities tailored to different age groups and individual needs.

A number of factors impact the ADHD market, including the rising prevalence of the disorder, increased awareness among physicians and patients, and advancements in diagnostic and treatment methods. However, challenges such as underdiagnosis, rigorous regulatory processes, and high medication costs may impede market growth in the future. The market is highly competitive, with several major pharmaceutical companies leading the way through significant investment in research and development and a wide range of products. These companies are dedicated to creating new and enhanced medications, including stimulant and non-stimulant options, to cater to the varied requirements of patients with ADHD.

Attention Deficit Hyperactivity Disorder Market Report Highlights

The stimulant drug category held the largest market share due to its established effectiveness and quick onset of action in the management of ADHD symptoms.

The hospital pharmacy sector is expected to experience significant growth in the coming years as awareness and diagnosis of ADHD continue to rise. This trend is leading to an increase in the number of patients seeking specialized care and comprehensive management plans, which are typically offered in hospital settings.

In 2023, North America dominated the market due to the high incidence of ADHD diagnoses. This can be attributed to increased awareness and acknowledgment of the disorder among healthcare providers and the general population in the region.

The global key market players include ADVANZ PHARMA, Amneal Pharmaceuticals LLC, Aytu BioPharma, Inc, Eli Lilly and Company, Johnson & Johnson Services, Inc, Lupin, Mallinckrodt, Novartis AG, Noven Pharmaceuticals, Inc, Sun Pharmaceutical Industries Ltd, Supernus Pharmaceuticals, Inc, Takeda Pharmaceutical Company Limited, Torrent Pharmaceuticals Ltd, Tris Pharma, Inc, Zevra Therapeutics, etc.

Polaris Market Research has segmented the artificial lift market report based on drug type, distribution channel, demographics, and region:

Attention Deficit Hyperactivity Disorder, Drug Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Stimulants
  • Non-Stimulants

Attention Deficit Hyperactivity Disorder, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Retail Pharmacy
  • Hospital Pharmacy

Attention Deficit Hyperactivity Disorder, Demographics Outlook (Revenue - USD Million, 2019 - 2032)

  • Children (2 to 17 years of age)
  • Adults

Attention Deficit Hyperactivity Disorder, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Austria
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Attention Deficit Hyperactivity Disorder Market Insights

  • 4.1. Attention Deficit Hyperactivity Disorder - Industry Snapshot
  • 4.2. Attention Deficit Hyperactivity Disorder Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Attention Deficit Hyperactivity Disorder
      • 4.2.1.2. Easy Availability of Behavioural Rehabilitation Therapies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of Proper Reimbursement
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Attention Deficit Hyperactivity Disorder Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Attention Deficit Hyperactivity Disorder Market, by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • 5.3. Stimulants
    • 5.3.1. Global Attention Deficit Hyperactivity Disorder Market, by Stimulants, by Region, 2019-2032 (USD Million)
  • 5.4. Non-stimulants
    • 5.4.1. Global Attention Deficit Hyperactivity Disorder Market, by Non-stimulants, by Region, 2019-2032 (USD Million)

6. Global Attention Deficit Hyperactivity Disorder Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • 6.3. Retail Pharmacy
    • 6.3.1. Global Attention Deficit Hyperactivity Disorder Market, by Retail Pharmacy, by Region, 2019-2032 (USD Million)
  • 6.4. Hospital Pharmacy
    • 6.4.1. Global Attention Deficit Hyperactivity Disorder Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Million)

7. Global Attention Deficit Hyperactivity Disorder Market, by Demographics

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • 7.3. Children (2 to 17 years of age)
    • 7.3.1. Global Attention Deficit Hyperactivity Disorder Market, by Children (2 to 17 years of age), by Region, 2019-2032 (USD Million)
  • 7.4. Adults
    • 7.4.1. Global Attention Deficit Hyperactivity Disorder Market, by Adults, by Region, 2019-2032 (USD Million)

8. Global Attention Deficit Hyperactivity Disorder Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Attention Deficit Hyperactivity Disorder Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Attention Deficit Hyperactivity Disorder Market - North America
    • 8.3.1. North America: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
    • 8.3.3. North America: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.4. Attention Deficit Hyperactivity Disorder Market - U.S.
      • 8.3.4.1. U.S.: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.5. Attention Deficit Hyperactivity Disorder Market - Canada
      • 8.3.5.1. Canada: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • 8.4. Attention Deficit Hyperactivity Disorder Market - Europe
    • 8.4.1. Europe: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
    • 8.4.3. Europe: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.4. Attention Deficit Hyperactivity Disorder Market - UK
      • 8.4.4.1. UK: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.5. Attention Deficit Hyperactivity Disorder Market - France
      • 8.4.5.1. France: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.4.5.3. France: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.6. Attention Deficit Hyperactivity Disorder Market - Germany
      • 8.4.6.1. Germany: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.7. Attention Deficit Hyperactivity Disorder Market - Italy
      • 8.4.7.1. Italy: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.8. Attention Deficit Hyperactivity Disorder Market - Spain
      • 8.4.8.1. Spain: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.9. Attention Deficit Hyperactivity Disorder Market - Netherlands
      • 8.4.9.1. Netherlands: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.10. Attention Deficit Hyperactivity Disorder Market - Russia
      • 8.4.10.1. Russia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • 8.5. Attention Deficit Hyperactivity Disorder Market - Asia Pacific
    • 8.5.1. Asia Pacific: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.4. Attention Deficit Hyperactivity Disorder Market - China
      • 8.5.4.1. China: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.5.4.3. China: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.5. Attention Deficit Hyperactivity Disorder Market - India
      • 8.5.5.1. India: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.5.5.3. India: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.6. Attention Deficit Hyperactivity Disorder Market - Malaysia
      • 8.5.6.1. Malaysia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.7. Attention Deficit Hyperactivity Disorder Market - Japan
      • 8.5.7.1. Japan: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.8. Attention Deficit Hyperactivity Disorder Market - Indonesia
      • 8.5.8.1. Indonesia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.9. Attention Deficit Hyperactivity Disorder Market - South Korea
      • 8.5.9.1. South Korea: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • 8.6. Attention Deficit Hyperactivity Disorder Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.4. Attention Deficit Hyperactivity Disorder Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.5. Attention Deficit Hyperactivity Disorder Market - UAE
      • 8.6.5.1. UAE: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.6. Attention Deficit Hyperactivity Disorder Market - Israel
      • 8.6.6.1. Israel: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.7. Attention Deficit Hyperactivity Disorder Market - South Africa
      • 8.6.7.1. South Africa: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • 8.7. Attention Deficit Hyperactivity Disorder Market - Latin America
    • 8.7.1. Latin America: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.4. Attention Deficit Hyperactivity Disorder Market - Mexico
      • 8.7.4.1. Mexico: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.5. Attention Deficit Hyperactivity Disorder Market - Brazil
      • 8.7.5.1. Brazil: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.6. Attention Deficit Hyperactivity Disorder Market - Argentina
      • 8.7.6.1. Argentina: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. ADVANZ PHARMA
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Amneal Pharmaceuticals LLC
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Aytu Biopharma, Inc
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Eli Lilly and Company
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Johnson & Johnson Services, Inc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Lupin
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mallinckrodt
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Novartis AG
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Noven Pharmaceuticals, Inc
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sun Pharmaceutical Industries Ltd
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Supernus Pharmaceuticals, Inc
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Takeda Pharmaceutical Company Limited
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Torrent Pharmaceuticals Ltd
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Tris Pharma, Inc
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Zevra Therapeutics
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Global Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 2 Global Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 3 Global Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 4 Attention Deficit Hyperactivity Disorder Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 6 North America: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 7 North America: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 8 U.S.: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 10 U.S.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 11 Canada: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 12 Canada: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 13 Canada: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 14 Europe: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 15 Europe: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 16 Europe: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 17 UK: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 18 UK: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 19 UK: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 20 France: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 21 France: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 22 France: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 23 Germany: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 24 Germany: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 25 Germany: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 26 Italy: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 27 Italy: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 28 Italy: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 29 Spain: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 30 Spain: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 31 Spain: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 32 Netherlands: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 34 Netherlands: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 35 Russia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 36 Russia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 37 Russia: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 41 China: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 42 China: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 43 China: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 44 India: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 45 India: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 46 India: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 47 Malaysia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 49 Malaysia: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 50 Japan: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 51 Japan: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 52 Japan: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 53 Indonesia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 55 Indonesia: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 56 South Korea: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 58 South Korea: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 65 UAE: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 66 UAE: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 67 UAE: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 68 Israel: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 69 Israel: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 70 Israel: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 71 South Africa: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 73 South Africa: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 74 Latin America: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 76 Latin America: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 77 Mexico: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 79 Mexico: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 80 Brazil: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 82 Brazil: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 83 Argentina: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 85 Argentina: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Attention Deficit Hyperactivity Disorder Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Distribution Channel
  • Figure 7. Global Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2021 & 2030 (USD Million)
  • Figure 8. Market by Drug Type
  • Figure 9. Global Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2021 & 2030 (USD Million)
  • Figure 10. Market by Demographics
  • Figure 11. Global Attention Deficit Hyperacti